Welcure Drugs & Pharmaceuticals Share Price Jumps 5% After Project Announcement

Market Performance

Welcure Drugs & Pharmaceuticals share price surged on Wednesday, August 20, 2025, as the stock touched its 5% upper circuit during intraday trade on the BSE.

• Previous Close: ₹12.10
• Opening Price: ₹12.70
• Upper Circuit Limit: ₹12.70

With this move, Welcure Drugs & Pharmaceuticals share price remained locked at the day’s upper band.

Main News

The sharp rise in Welcure Drugs & Pharmaceuticals share price followed the company’s disclosure to the exchanges on August 20, 2025.

The company announced plans to set up a new Agro-Pharma Research Laboratory and scheduled a Board Meeting on August 28, 2025, to discuss fundraising through a Qualified Institutional Placement (QIP).

Company Developments

Welcure Drugs & Pharmaceuticals highlighted key details of its upcoming project:

• Objective: To develop and scale technologies that transform agricultural and botanical inputs into pharmaceutical-grade products.
• Estimated Project Cost: ₹70–80 crore
• Investment Scope: Laboratory infrastructure, pilot lines, analytics, and quality systems
• Next Steps: Finalization of implementation site, timeline, and commissioning plan after clearances

The company stated that the project is designed to support public health and societal well-being through innovation in agro-pharma research.

Company Profile

Founded in 1992 by Dharam Chand Jain, Welcure Drugs & Pharmaceuticals is an Indian firm engaged in the manufacturing and trading of:

• Bulk pharmaceuticals
• Drug intermediates
• Pharmaceutical formulations
• Medical items

Over the years, the company has expanded its portfolio across multiple segments of the pharma sector.

Summary

• Welcure Drugs & Pharmaceuticals share price hit the 5% upper circuit on August 20, 2025.
• Stock opened at ₹12.70 compared to the previous close of ₹12.10.
• Surge followed the announcement of a new Agro-Pharma Research Laboratory project.
• The project involves an estimated investment of ₹70–80 crore with funding plans via QIP.
• The initiative is aimed at advancing agro-based pharmaceutical innovations in India.